Literature DB >> 28211646

Observational study on the dispensing of cough syrups to children with acute cough by community pharmacists in France.

François-André Allaert1,2, Stéphanie Villet3, Stéphane Vincent4, Laurent Sauve5.   

Abstract

BACKGROUND: Over-the-counter medicines may be proposed by pharmacists for children with acute cough. Study objectives were to describe the sociodemographic profile of children who were proposed a cough syrup by a pharmacist, the nature of the cough and type(s) of cough syrup proposed and to assess the evolution of the cough, tolerance and satisfaction with treatment.
METHODS: Observational, prospective, longitudinal, multicentre study with 157 pharmacies in France. Children who were proposed a cough syrup by a pharmacist were recruited. Questionnaires were completed by the pharmacists and/or parents at inclusion and by the parents after 5 days of treatment.
RESULTS: Four hundred fourteen children were included (mean age: 6.0±2.9 years); 45.9% had a dry and 43.3% a productive cough. 30.4% were proposed an allopathic antitussive syrup, 28.3% an allopathic expectorant syrup and 23.7% a homeopathic syrup. Children with a dry cough were more likely to be given an allopathic antitussive (55.2%) or homeopathic (28.2%) syrup. Children with a productive cough or cough of several days duration were more likely to be given an allopathic expectorant syrup (70.1%). Cough disappearance was more frequent with homeopathic syrups compared to allopathic expectorants (P=0.002), or allopathic antitussives (P=0.042). Adverse events were most common with allopathic antitussive syrups (18.7%) (P<0.001). Two-thirds of parents were satisfied with the treatment their child received.
CONCLUSIONS: Pharmacists play an important role in the management of acute cough in children. Homeopathic cough syrups may have an interest in terms of public health.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28211646     DOI: 10.23736/S0026-4946.17.04752-1

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  2 in total

Review 1.  Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease.

Authors:  Kate Summer; Jessica Browne; Lei Liu; Kirsten Benkendorff
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

2.  Low-dose Drosera rotundifolia induces gene expression changes in 16HBE human bronchial epithelial cells.

Authors:  Fabio Arruda-Silva; Paolo Bellavite; Marta Marzotto
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.